ABUSE FORM
Mario Maj - Depressive Disorders
Posted By :
Tino Gara
|
Date :
16 Jan 2009 00:33:00
|
Comments :
1
|
|
Mario Maj - Depressive Disorders (Wpa Series in Evidence & Experience in Psychiatry Vol 1)
Wiley | ISBN: 0470849651 | 21/02/2003 | English | 506 pages | PDF | 2 MB
Wiley | ISBN: 0470849651 | 21/02/2003 | English | 506 pages | PDF | 2 MB
In this new edition of the first volume of the WPA Series, Evidence and Experience in Psychiatry, issues surrounding depressive disorders are examined in a unique and highly informative manner. The six systematic reviews, written by outstanding authors, focus on key topics such as the choice and duration of drug treatment and the cost of depressive disorders. They are accompanied by commentaries giving advice from clinicians of different orientations and countries.
From Chapter 1 "Depression, like many other mental disorders, is characterised by the presence of a number of symptoms which are changeable over time." Among these symptoms are a depressed mood and a loss of interest; physical and cognitive changes may also occur. Because of difficulties in diagnosis (and varied criteria) only estimates in the global number of cases of depression can be made. Some estimates put it in front of chronic heart disease as a health problem and cause of death.
This revised edition covers developments in diagnosis, theraphy, prognosis, economic evaluation and quality improvement.
* Provides accompanying commentaries by an outstanding line up of contributors
* Covers developments in diagnosis, therapy, prognosis, economic evaluation and quality improvement
* Provides an unbiased and reliable reference point
Review
| “ | "The editors should be commended for commissioning separate chapters on young and old people." (International Psychogeriatrics Vol.16.No.2 2004) | ” |
Be Guided by the Evidence…
In this new edition of the first volume of the WPA Series, Evidence and Experience in Psychiatry, issues surrounding depressive disorders are examined in a unique and highly informative manner. The six systematic reviews, written by outstanding authors, focus on key topics such as the choice and duration of drug treatment and the cost of depressive disorders. They are accompanied by commentaries giving advice from clinicians of different orientations and countries.
This revised and updated volume:
*Gives the best available evidence to enable well-informed clinical decision making
*Covers developments in diagnosis, therapy, prognosis, economic evaluation and quality improvement
*Summarises the ‘evidence’ and the ‘experience’ to provide an unbiased and reliable reference point
*Comprehensively itemises and evaluates the relevant points
This new edition provides insights that will prove invaluable to psychiatrists, psychologists, mental health nurses, managers and policy makers.
| ADVERTISING » | High Speed Download | « ADVERTISING |
Recent searches:
Contents
List of Review Contributors xiii
Preface xv
CHAPTER 1 DIAGNOSIS OF DEPRESSIVE DISORDERS 1
Diagnosis of Depressive Disorders: A Review 1
COMMENTARIES
1.1 Much Diversity, Many Categories, No Entities 52
1.2 Categorical and Dimensional Perspectives of Depression 54
J. Angst
1.3 Models of Classification of Depressive Disorders 57
1.4 Flaws of Current Diagnosis of Depression 59
1.5 Approaches to Diagnosing Depression, and the Reciprocal Relationship to Depression Research 63
1.6 The Practical Importance of Temporal Sequencing and Secondary Depression 65
1.7 Depression: the Complexity of its Interface with Soft Bipolarity 68
1.8 Contextualizing the Diagnosis of Depression 71
1.9 Age, Loss and the Diagnostic Boundaries of Depression 73
1.10 Depression Among Elderly and Postpartum Women 75
1.11 Self-rating Depression Scales: Some Methodological Issues 77
1.12 Underdiagnosis of Depression: Its Impact on the Community 79
1.13 Limited Options on Diagnosing Depression 82
1.14 Diagnosis of Depressive Disorders: Taxonomical Systems and Clinical Practice 83
1.15 The Identification of Diagnostic Subtypes of Depressive Disorders 85
CHAPTER 2 PHARMACOLOGICAL TREATMENT OF DEPRESSIVE DISORDERS 89
Pharmacological Treatment of Depressive Disorders: A Review 89
COMMENTARIES
2.1 Antidepressants: Forty Years of Experience 129
2.2 Targeting Antidepressant Treatment: The Evidence is Weak 131
2.3 The Selection of the Antidepressant in Clinical Practice 133
2.4 Gender and Antidepressant Response 135
2.5 Validity of Atypical Depression: Evidence Provided by Pharmacological Dissection 138
2.6 Increasing Our Understanding of the Working Mechanism of Antidepressants 140
2.7 Are the First Generation Monoamine Reuptake Inhibitors Still Needed in the Treatment of Major Depressive Episode? 142
2.8 Antidepressants in Broader Context 144
2.9 Antidepressants for Better Quality of Life 146
2.10 Would Rational Polypharmacy Improve Quality of Life? 148
2.11 Compliance Issues and the Efficacy of Antidepressants 150
2.12 The Parallel Need for Medicine-based Evidence 152
2.13 What is a Lot of Antidepressants for so Few Criteria of Choice? 155
2.14 Depression and its Treatment: a General Health Problem 157
2.15 Antidepressant Drugs: The Indian Experience 159
CHAPTER 3 PSYCHOTHERAPIES FOR DEPRESSIVE DISORDERS 161
Psychotherapies for Depressive Disorders: A Review 161
COMMENTARIES
3.1 Latest Developments in Psychotherapy for Depression 207
3.2 Indications and Planning of Psychotherapies: "Much Ado about Nothing"? 209
3.3 The State of Antidepressant Psychotherapy: Growing Strengths, Still Unanswered Questions 212
3.4 Research on Hot-house Psychotherapy 214
3.5 Psychotherapy for Depression: Are Additional Controlled Trials Still Warranted? 216
3.6 Depression: The Evidence forWhatWorks and What Doesn’t 219
3.7 Psychotherapy of Depression: Research and Practice 221
3.8 Nosology vs. Personality Directed Psychotherapy and the Gap Between Research and Practice 223
3.9 The Sequential Use of Pharmacotherapy and Psychotherapy in Depressive Disorders 226
3.10 Integrating Psychotherapies in Clinical Practice 228
3.11 Building on the Foundations: Where Next in Therapeutic Outcome Research? 230
CHAPTER 4 DEPRESSIVE DISORDERS IN CHILDREN AND ADOLESCENTS 233
Depressive Disorders in Children and Adolescents: A Review 233
COMMENTARIES
4.1 Towards an Understanding of Early Onset Depression 267
4.2 Depression In Youth: Trends in Diagnosis 269
4.3 Depressive Disorders in Childhood and Adolescence: State of the Art 271
4.4 "At least in the form seen in adults." A Commentary on Major Depressive Disorder in Youth 273
4.5 The "Atypicality" of Depression in Youth 276
4.6 How the Study of Early Onset Depression Challenges Us to Produce a New Paradigm for Understanding Mood Disorders 278
4.7 Adult and Childhood Depressions May in Fact be Different Illnesses 281
4.8 Taking Stock and Moving on: Current Issues and Challenges Concerning Child and Adolescent Depressive Disorders 283
4.9 Increasing Awareness of Depressive Disorders in Childhood: Implications for World Child and Adolescent Mental Health 286
4.10 Some Unsolved Problems in Childhood Depression: A Clinician’s View 289
4.11 Childhood Depression: Some Unresolved Research Questions 292
4.12 Research Trends in Depressive Disorders of Youth 295
4.13 The Nature of First Episode Major Depression in Childhood and Adolescence 297
4.14 Clinical Update of Child and Adolescent Depression 299
4.15 Treatment Controversies in Childhood Depression 302
4.16 Psychotherapy for Childhood Depression 304
4.17 Role of Neurobiological and Genetic Factors in Treatment of Childhood Depression 306
4.18 Depression in the Family 309
CHAPTER 5 DEPRESSIVE DISORDERS IN THE ELDERLY 313
Depressive Disorders in the Elderly: A Review 313
COMMENTARIES
5.1 Depression in Older Age: Diagnostic Problems, New Knowledge and Neglected Areas 364
5.2 Depression in the Elderly is Underdiagnosed; Etiology is Multifactorial 366
5.3 Depression in the Elderly: Issues in Diagnosis and Management 369
5.4 Depressive Disorders in the Elderly: A Fresh Perspective 371
5.5 Depression in the Elderly: Areas Open to Research 373
5.6 Filling in the Gaps about Depression in the Elderly 376
5.7 A Clinical Point of View about Depression in the Elderly 377
5.8 Geriatric Depression: A Look to the Future 379
5.9 Depression in Late Life: Directions for Intervention Research 382
5.10 Treatment of Depression in the "Old-old" 384
5.11 Suggested Priorities for Research into Depressive Disorders in the Elderly 386
5.12 Comorbidity of Depression in Older People 388
5.13 Myth or Reality of Old Age Depression: The Example of Taiwan Studies 390
5.14 Depression in the Elderly: Predictors and Prognostic Factors 392
5.15 Risk and Protective Factors in Elderly Depression 394
5.16 Depression in Elderly Chinese 396
5.17 Suicide in Old Age 398
CHAPTER 6 COSTS OF DEPRESSIVE DISORDERS 401
Costs of Depressive Disorders: A Review 401
COMMENTARIES
6.1 Economics of Depression and its Treatment: Why Are We So Interested? 450
6.2 Economic Evidence and Policy Decisions 452
6.3 Cost-effectiveness of Treatment for Depression: Methods and Policies 456
6.4 Costs of Treating Depression: Policy Should Be Evidence-based 459
6.5 Economic Costs and Benefits of Depression Treatment from Naturalistic Studies 461
6.6 Compliance: Another Factor in Estimating the Cost of Depression 463
6.7 Capturing the Cost of Depressive Disorders in the Natural Laboratory of the Workplace 465
6.8 Depression Management: No Longer At All Costs 468
6.9 Limitations to Cost Assessments of Depressive Disorders 470
6.10 Understanding the Economic Implications of Depression 472
6.11 The Burden of Depression and the Importance of Educational Programmes 474
6.12 Therapy of Depression Means Less Cost Than What is Otherwise Lost 476
6.13 Economic Aspects of Depression: the Experience of Developing Countries 478
Acknowledgements for the First Edition 481
Index 483